Variant report

Variant	esv3342190
Chromosome Location	chr7:137530512-137532910
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:138)
CpG islands
(count:610)
Chromatin interactive
region (count:2)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:138 , 50 per page) page: 1 2 3

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BHLHE40	chr7:137531829-137531960	GM12878	blood:	n/a	chr7:137531943-137531959
2	BHLHE40	chr7:137532424-137532751	GM12878	blood:	n/a	n/a
3	CEBPD	chr7:137531661-137531893	HepG2	liver:	n/a	n/a
4	CHD2	chr7:137531727-137531824	HepG2	liver:	n/a	n/a
5	CTBP2	chr7:137531074-137532426	H1-hESC	embryonic stem cell:	n/a	n/a
6	CTCF	chr7:137531111-137531193	MCF-7	breast:	n/a	n/a
7	CTCF	chr7:137531100-137531250	SK-N-SH_RA	brain:	n/a	n/a
8	CTCF	chr7:137531111-137531184	MCF-7	breast:	n/a	n/a
9	CTCF	chr7:137531104-137531173	Fibrobl	skin:	n/a	n/a
10	CTCF	chr7:137531980-137532130	AG09319	gingival:	n/a	n/a
11	CTCF	chr7:137531920-137532070	AG04449	skin:	n/a	n/a
12	CTCF	chr7:137531094-137531185	MCF-7	breast:	n/a	n/a
13	CTCF	chr7:137531940-137532090	BJ	skin:	n/a	n/a
14	CTCF	chr7:137531116-137531162	GM19238	blood:	n/a	n/a
15	CTCF	chr7:137531095-137531210	GM12891	blood:	n/a	n/a
16	CTCF	chr7:137532240-137532390	SK-N-SH_RA	brain:	n/a	n/a
17	CTCF	chr7:137530960-137531110	GM12872	blood:	n/a	n/a
18	CTCF	chr7:137531060-137531210	AG04449	skin:	n/a	n/a
19	CTCF	chr7:137531940-137532090	HCPEpiC	choroid plexus:	n/a	n/a
20	CTCF	chr7:137531092-137531181	GM19239	blood:	n/a	n/a
21	CTCF	chr7:137531980-137532130	HBMEC	blood vessel:	n/a	n/a
22	CTCF	chr7:137531080-137531230	SK-N-SH_RA	brain:	n/a	n/a
23	CTCF	chr7:137532300-137532450	AG10803	skin:	n/a	n/a
24	CTCF	chr7:137531080-137531230	HRE	kidney:	n/a	n/a
25	CUX1	chr7:137532402-137532683	GM12878	blood:	n/a	n/a
26	EBF1	chr7:137532397-137532636	GM12878	blood:	n/a	n/a
27	ELF1	chr7:137530932-137532469	GM12878	blood:	n/a	chr7:137532396-137532407 chr7:137531161-137531173 chr7:137531126-137531135
28	ELK1	chr7:137532491-137532531	GM12878	blood:	n/a	n/a
29	EP300	chr7:137532444-137532702	GM12878	blood:	n/a	n/a
30	EP300	chr7:137532409-137532609	GM12878	blood:	n/a	n/a
31	FOSL2	chr7:137532883-137533345	HepG2	liver:	n/a	n/a
32	FOSL2	chr7:137530926-137532719	HepG2	liver:	n/a	n/a
33	GABPA	chr7:137532114-137532455	H1-hESC	embryonic stem cell:	n/a	n/a
34	HDAC2	chr7:137531482-137531730	HepG2	liver:	n/a	n/a
35	MAFF	chr7:137532463-137533112	HepG2	liver:	n/a	chr7:137532970-137532984
36	MAFK	chr7:137532418-137533117	HepG2	liver:	n/a	chr7:137532967-137532987 chr7:137532969-137532985
37	MAFK	chr7:137532435-137533096	HepG2	liver:	n/a	chr7:137532967-137532987 chr7:137532969-137532985
38	MAFK	chr7:137532454-137533160	IMR90	lung:	n/a	chr7:137532967-137532987 chr7:137532969-137532985
39	MAX	chr7:137532213-137532489	H1-hESC	embryonic stem cell:	n/a	n/a
40	MAX	chr7:137532325-137532581	GM12878	blood:	n/a	n/a
41	MAX	chr7:137531259-137531951	SK-N-SH	brain:	n/a	chr7:137531929-137531939
42	MAZ	chr7:137532164-137532632	GM12878	blood:	n/a	n/a
43	MAZ	chr7:137529826-137532738	IMR90	lung:	n/a	chr7:137532088-137532098 chr7:137531929-137531939
44	MAZ	chr7:137531587-137531676	GM12878	blood:	n/a	n/a
45	MBD4	chr7:137531641-137532114	HepG2	liver:	n/a	n/a
46	MXI1	chr7:137532191-137532502	GM12878	blood:	n/a	n/a
47	MXI1	chr7:137532832-137532838	GM12878	blood:	n/a	n/a
48	NFYB	chr7:137531623-137531815	K562	blood:	n/a	n/a
49	NFYB	chr7:137531530-137531875	GM12878	blood:	n/a	n/a
50	POLR2A	chr7:137531715-137532764	GM12891	blood:	n/a	n/a

(count:610 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr7:137531697-137531747	HCT-116	colon:	n/a
2	chr7:137532857-137532907	NHDF-neo	bronchial:	n/a
3	chr7:137531697-137531747	T-47D	breast:	n/a
4	chr7:137532374-137532424	K562	blood:	n/a
5	chr7:137532857-137532907	NH-A	brain:	n/a
6	chr7:137532374-137532424	HRE	kidney:	n/a
7	chr7:137531791-137531841	SAEC	small airway:	n/a
8	chr7:137531956-137532006	PFSK-1	brain:	n/a
9	chr7:137531791-137531841	AG09309	skin:	n/a
10	chr7:137531956-137532006	HRE	kidney:	n/a
11	chr7:137531956-137532006	HepG2	liver:	n/a
12	chr7:137532374-137532424	HRPEpiC	eye:	n/a
13	chr7:137531173-137531223	BJ	skin:	n/a
14	chr7:137531952-137532002	SKMC	muscle:	n/a
15	chr7:137532374-137532424	HCM	heart:	n/a
16	chr7:137532857-137532907	Jurkat	blood:	n/a
17	chr7:137531258-137531308	HCT-116	colon:	n/a
18	chr7:137531791-137531841	GM06990	blood:	n/a
19	chr7:137531801-137531851	Jurkat	blood:	n/a
20	chr7:137532857-137532907	HCT-116	colon:	n/a
21	chr7:137531956-137532006	NHDF-neo	bronchial:	n/a
22	chr7:137531173-137531223	HIPEpiC	eye:	n/a
23	chr7:137531612-137531662	AG09309	skin:	n/a
24	chr7:137531801-137531851	HepG2	liver:	n/a
25	chr7:137532374-137532424	PANC-1	pancreas:	n/a
26	chr7:137531612-137531662	K562	blood:	n/a
27	chr7:137531258-137531308	Caco-2	colon:	n/a
28	chr7:137531258-137531308	HEK293	kidney:	embryo
29	chr7:137531791-137531841	Hepatocyte	liver:	n/a
30	chr7:137531956-137532006	HNPCEpiC	eye:	n/a
31	chr7:137531956-137532006	Jurkat	blood:	n/a
32	chr7:137531612-137531662	Jurkat	blood:	n/a
33	chr7:137531612-137531662	MCF-7	breast:	n/a
34	chr7:137531697-137531747	AoSMC	blood vessel:	n/a
35	chr7:137531697-137531747	AG09309	skin:	n/a
36	chr7:137531258-137531308	RPTEC	kidney:	n/a
37	chr7:137531952-137532002	H1-hESC	embryonic stem cell:	embryo
38	chr7:137532374-137532424	Jurkat	blood:	n/a
39	chr7:137531791-137531841	GM19239	blood:	n/a
40	chr7:137532374-137532424	PFSK-1	brain:	n/a
41	chr7:137531952-137532002	HL-60	blood:	n/a
42	chr7:137532374-137532424	T-47D	breast:	n/a
43	chr7:137531697-137531747	Hela-S3	cervix:	n/a
44	chr7:137531801-137531851	SKMC	muscle:	n/a
45	chr7:137531258-137531308	IMR90	lung:	fetal
46	chr7:137531952-137532002	ECC-1	luminal epithelium:	n/a
47	chr7:137531956-137532006	K562	blood:	n/a
48	chr7:137532857-137532907	SK-N-MC	brain:	n/a
49	chr7:137531952-137532002	HCPEpiC	choroid plexus:	n/a
50	chr7:137531697-137531747	NHBE	bronchial:	n/a

(count:2 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr7:137521731..137523551-chr7:137529090..137530870,2	K562	blood:
2	chr7:137527969..137530649-chr7:137533553..137535061,2	MCF-7	breast:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-AKR1D1-5	chr7:137531776-137533814	NONHSAT123588

No data

Variant related genes	Relation type
DGKI	TF binding region
DGKI	CpG island

Extended variants
information (count: 76 )
Associated
traits (count: 87 )

Variant overlapped rSNPs/rCNVs (count:76 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs375615949	chr7:137530582-137530583	Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs1871213	chr7:137530583-137530584	Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs548712546	chr7:137530590-137530591	Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs79267386	chr7:137530595-137530596	Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs184525682	chr7:137530668-137530669	Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Active TSS Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs530736474	chr7:137530762-137530763	Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Active TSS Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs62490520	chr7:137530880-137530881	Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs138727612	chr7:137530907-137530908	Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs367644651	chr7:137530908-137530909	Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs3054922	chr7:137530909-137530910	Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs201151305	chr7:137530911-137530912	Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs199586972	chr7:137530913-137530914	Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs58484819	chr7:137530940-137530941	Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs142710455	chr7:137530955-137530956	Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs113602809	chr7:137530980-137530981	Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs78350328	chr7:137531017-137531018	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs181202808	chr7:137531067-137531068	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs566507052	chr7:137531087-137531088	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs183892716	chr7:137531116-137531117	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs555448957	chr7:137531123-137531124	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs568280359	chr7:137531137-137531138	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs200812531	chr7:137531148-137531149	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs537270023	chr7:137531152-137531153	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs371653759	chr7:137531159-137531160	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs373980708	chr7:137531163-137531164	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs376682810	chr7:137531168-137531169	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs141032469	chr7:137531200-137531201	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs201406327	chr7:137531213-137531214	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs546516751	chr7:137531231-137531232	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs556060323	chr7:137531238-137531239	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs377186477	chr7:137531264-137531265	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs149148227	chr7:137531282-137531283	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
33	rs541920248	chr7:137531307-137531308	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
34	rs562183222	chr7:137531384-137531385	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs531052468	chr7:137531426-137531427	Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs527683728	chr7:137531515-137531516	Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs142433066	chr7:137531546-137531547	Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs564311171	chr7:137531656-137531657	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
39	rs117303154	chr7:137531697-137531698	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
40	rs546875108	chr7:137531703-137531704	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
41	rs566304264	chr7:137531710-137531711	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
42	rs528897321	chr7:137531826-137531827	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Weak transcription	TF binding region CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a
43	rs189540670	chr7:137531832-137531833	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Weak transcription	TF binding region CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a
44	rs375915123	chr7:137531841-137531842	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Weak transcription	TF binding region CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a
45	rs34309725	chr7:137531952-137531953	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Weak transcription	TF binding region CpG island lncRNA	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
46	rs561960763	chr7:137531956-137531957	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Weak transcription	TF binding region CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a
47	rs115759654	chr7:137531984-137531985	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Weak transcription	TF binding region CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a
48	rs115105610	chr7:137532012-137532013	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Weak transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
49	rs539700629	chr7:137532014-137532015	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Weak transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
50	rs553641461	chr7:137532015-137532016	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Weak transcription	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:87)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Thyroid cancer	19087340	CNVD
Seminomas	18059402	CNVD
Testicular cancer	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Autism	19415332	CNVD
Medulloblastoma	21979893	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
T-cell lymphomas	19863542	CNVD
Malaria	21533027	CNVD
Melanoma	18172304	CNVD
Renal cell carcinoma	19461508	CNVD
head and neck squamous cell carcinoma	19289630	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Ewing''s sarcoma	17952124	CNVD
Wilms tumour	21544195	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Squamous cell cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Glioblastoma multiforme	17387387	CNVD
Low-grade fibromyxoid sarcoma	0	CNVD
Oligodendroglial tumors	17285580	CNVD
Endometrial cancer	22040021	CNVD
Burkitt''s lymphoma	18698080	CNVD
Breast cancer	21264507	CNVD
Shwachman-Diamond syndrome	22934832	CNVD
Colorectal cancer	19359472	CNVD
Cutaneous malignant melanoma	17690212	CNVD
Leukemia	17361228	CNVD
Breast cancer	16461572	CNVD
Peripheral t-cell lymphoma	19118030	CNVD
Malignant melanoma	17690212	CNVD
Renal cell carcinoma	18592004	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Multiple myeloma	17550852	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Neurodevelopmental disorder	22521361	CNVD
abortions and stillbirths	19751515	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Burkitt''s lymphoma	19759907	CNVD
Chronic myeloid leukemia	21384125	CNVD
Breast cancer	21858162	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
lymphocytic leukemia	21291569	CNVD
Acute myeloid leukemia	21251322	CNVD
Prostate cancer	16573809	CNVD
Medulloblastoma	16783165	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Melanoma	19188590	CNVD
Glioblastoma multiforme	18628472	CNVD
abnormal development	18461090	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Malignant melanoma	17260012	CNVD
Coffin-Siris syndrome	21572526	CNVD
Papillary thyroid carcinoma	21436994	CNVD
small cell lung cancer	20016488	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Hodgkin''s lymphoma	18179710	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Breast cancer	21509527	CNVD
Breast cancer	16272173	CNVD
Myxofibrosarcoma	16751306	CNVD
Stuttering	21108403	CNVD
Breast cancer	17603634	CNVD
Urothelial carcinoma	18382360	CNVD
Neuroticism	17667963	CNVD
Myelodysplastic syndrome	17634407	CNVD
Acute myeloid leukemia	17237825	CNVD
Esophageal cancer	21851588	CNVD
Bladder cancer	21909424	CNVD
Cancer	21129771	CNVD
Myelofibrosis	22110671	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
T-cell acute lymphoblastic leukemia	16673021	CNVD
Cancer	21183584	CNVD
Intracranial ependymoma	16609018	CNVD
Non-small cell lung cancer	21829676	CNVD
Developmental delay	19490664	CNVD
Pancreatitis	20877625	CNVD
Multiple myeloma	16461302	CNVD
Neuroblastoma	18923191	CNVD

Chromatin state (count:423 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr7:137521800-137530800	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
2	chr7:137527200-137532600	Active TSS	Brain Anterior Caudate	brain
3	chr7:137527600-137530600	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
4	chr7:137528600-137530800	Flanking Active TSS	Fetal Brain Female	brain
5	chr7:137528600-137532800	Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
6	chr7:137528800-137530600	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
7	chr7:137528800-137530600	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
8	chr7:137528800-137532800	Active TSS	Brain Inferior Temporal Lobe	brain
9	chr7:137529400-137530800	Flanking Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
10	chr7:137529400-137531200	Flanking Active TSS	Muscle Satellite Cultured Cells	--
11	chr7:137529600-137531200	Flanking Active TSS	Fetal Brain Male	brain
12	chr7:137529800-137530600	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
13	chr7:137529800-137530600	Bivalent Enhancer	iPS DF 6.9 Cell Line	embryonic stem cell
14	chr7:137529800-137531000	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
15	chr7:137530000-137530600	Bivalent Enhancer	HepG2	liver
16	chr7:137530200-137530800	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
17	chr7:137530200-137530800	Flanking Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
18	chr7:137530200-137530800	Flanking Active TSS	Brain Angular Gyrus	brain
19	chr7:137530200-137530800	Flanking Active TSS	Brain Germinal Matrix	brain
20	chr7:137530400-137530600	Flanking Bivalent TSS/Enh	Brain Cingulate Gyrus	brain
21	chr7:137530400-137530600	Flanking Active TSS	HSMM	muscle
22	chr7:137530400-137530800	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
23	chr7:137530400-137530800	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
24	chr7:137530400-137530800	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
25	chr7:137530400-137530800	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
26	chr7:137530400-137530800	Bivalent Enhancer	Fetal Intestine Large	intestine
27	chr7:137530400-137531000	Bivalent Enhancer	Adipose Nuclei	Adipose
28	chr7:137530400-137531000	Flanking Active TSS	Brain Hippocampus Middle	brain
29	chr7:137530400-137531000	Bivalent Enhancer	Fetal Muscle Leg	muscle
30	chr7:137530400-137531000	Enhancers	Gastric	stomach
31	chr7:137530400-137531000	Flanking Active TSS	HSMMtube	muscle
32	chr7:137530400-137531200	Flanking Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived
33	chr7:137530400-137531200	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
34	chr7:137530400-137531200	Flanking Active TSS	Brain Substantia Nigra	brain
35	chr7:137530400-137531200	Flanking Active TSS	Osteobl	bone
36	chr7:137530400-137531800	Bivalent Enhancer	Fetal Muscle Trunk	muscle
37	chr7:137530400-137531800	Active TSS	NH-A	brain
38	chr7:137530400-137532800	Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
39	chr7:137530600-137530800	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
40	chr7:137530600-137530800	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
41	chr7:137530600-137530800	Flanking Active TSS	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
42	chr7:137530600-137530800	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
43	chr7:137530600-137530800	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
44	chr7:137530600-137530800	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
45	chr7:137530600-137530800	Bivalent/Poised TSS	Brain Cingulate Gyrus	brain
46	chr7:137530600-137530800	Flanking Bivalent TSS/Enh	HepG2	liver
47	chr7:137530600-137531000	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
48	chr7:137530600-137531000	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
49	chr7:137530600-137531000	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
50	chr7:137530600-137531000	Bivalent Enhancer	Skeletal Muscle Female	skeletal muscle

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links